Holdings
36
Concentrated
Top 10 weight
52%
Concentration
Active share
-
Style
Equity
97%
Asset allocation
Portfolio
-Sectors
4High-conviction bets
-Top sector wt.
0.2%Cash
Market-cap allocation
Large cap34%
Mid cap25%
Small cap39%
Asset allocation
Equity97%
Top holdings
8.5%
5.7%
5.5%
DIVI LABORATORIES LTDEQUITY
5.1%ABBOTT INDIA LTDEQUITY
5.0%CIPLA LTDEQUITY
4.8%4.6%
4.4%
4.3%
4.1%
MANKIND PHARMA LTDEQUITY
3.9%FORTIS HEALTHCARE LTDEQUITY
3.4%BAYER CROPSCIENCE LTDEQUITY
3.2%LUPIN LTDEQUITY
2.8%2.7%
ALKEM LABORATORIES LTDEQUITY
2.6%SAI LIFE SCIENCES LTDEQUITY
2.5%PFIZER LTDEQUITY
2.5%CASH / NET CURRENT ASSETCASH_EQUIVALENT
2.3%FDC LTDEQUITY
2.3%GLOBAL HEALTH LTDEQUITY
2.3%1.8%
CONCORD BIOTECH LTDEQUITY
1.8%DR. LAL PATH LABS LTDEQUITY
1.6%NEULAND LABORATORIES LTDEQUITY
1.6%AJANTA PHARMA LTDEQUITY
1.6%SANOFI INDIA LTDEQUITY
1.5%1.5%
GILLETTE INDIA LTDEQUITY
1.2%1.0%
1.0%
JUBILANT PHARMOVA LTDEQUITY
0.9%0.6%
IPCA LABORATORIES LTDEQUITY
0.6%ZIM LABORATORIES LTDEQUITY
0.5%F) REPOCASH
0.2%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- Small-cap heavy (39%) - higher volatility.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
59.7%
32.3%
4.2%
1.2%